Highlight Capital logo

Highlight Capital

Asia, Jiangsu, China, Nanjin

Description

Highlight Capital is an investment firm dedicated to support healthcare companies to generate robust and sustained growth prospect.

Investor Profile

Highlight Capital has made 28 investments, with 11 in the past 12 months and 43% as lead.

Stage Focus

  • Seed (21%)
  • Series C (21%)
  • Series A (21%)
  • Series Unknown (11%)
  • Series B (11%)
  • Series D (7%)
  • Post Ipo Equity (4%)
  • Debt Financing (4%)

Country Focus

  • China (75%)
  • United States (18%)
  • Indonesia (4%)
  • South Korea (4%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical
  • Therapeutics
  • Manufacturing
  • Internet
  • Biopharma
  • Artificial Intelligence (Ai)
  • Robotics
  • Software
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Highlight Capital frequently co-invest with?

Amgen Ventures
North America, California, United States, San Francisco
Co-Investments: 2
Cowin Capital
Asia, Guangdong, China, Shenzhen
Co-Investments: 2
Hidden Hill Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 2
Frazier Healthcare Partners
North America, Washington, United States, Seattle
Co-Investments: 2
Matrix Partners China
Asia, Beijing, China, Beijing
Co-Investments: 2
General Atlantic
North America, New York, United States, New York
Co-Investments: 2
Greenspring Associates
North America, Maryland, United States, Owings Mills
Co-Investments: 2
Fortune Venture Capital
Asia, Guangdong, China, Shenzhen
Co-Investments: 2

What are some of recent deals done by Highlight Capital?

LongBio Pharma

Pudong, Shandong, China

LongBio Pharma is a biotech company that treats patients with an emphasis on complement and allergy diseases.

BiotechnologyMedicalPharmaceutical
Series CMay 27, 2025
Amount Raised: $27,822,216
Acchrom Tech

Huairou, Beijing, China

Acchrom Tech is a technology company focusing on high-end liquid chromatography.

Medical Device
Series BMay 13, 2025
Amount Raised: $13,882,526
Nuevocor

Singapore, Central Region, Singapore

Nuevocor operates as a preclinical-stage biotech company.

BiopharmaBiotechnologyMedicalPharmaceutical
Series BMay 6, 2025
Amount Raised: $45,000,000
Hongpu Technology

Hangzhou, Zhejiang, China

Hongpu Technology is a high-end instrument independent research and development company.

IndustrialIndustrial EngineeringTechnical Support
SeedApr 21, 2025
Qianxun Intelligence

Hangzhou, Zhejiang, China

Qianxun Intelligence is an intelligent technology developer that offers software development, intelligent robot research and development.

InternetSoftware
SeedMar 31, 2025
Amount Raised: $72,808,505
ZhongQing Robot

Shenzhen, Guangdong, China

Zhongqing Robotics focuses on intelligent robots and industry solutions, including humanoid robots.

Artificial Intelligence (AI)Robotic Process Automation (RPA)Robotics
SeedFeb 20, 2025
Methuselah

Shanghai, Shanghai, China

Methuselah is a medical nutrition company that produces nutrition products.

Health CareHospitalMedical
Series BFeb 19, 2025
Amount Raised: $27,457,818
Jiamai shares

Longgang, Guangdong, China

Jiamai is a new energy pneumatic component manufacturer.

BatteryEnergyLaserManufacturing
Series UnknownFeb 18, 2025
Amount Raised: $13,736,264
Shengfang Technology

Shenzhen, Guangdong, China

Shengfang Technology is a high-tech company that combines sales, service, production, and research and development for excimer lasers.

LaserManufacturing
Series AJan 15, 2025
TOYA

Dongguang, Guangdong, China

TOYA specializes in the production of ultra-fine copper and copper alloy conductors.

ElectronicsManufacturingSemiconductor
Series CDec 27, 2024